Diana Conte Camerino Selected Research

Prodrugs

2/2012

Synthesis and toxicopharmacological evaluation of m-hydroxymexiletine, the first metabolite of mexiletine more potent than the parent compound on voltage-gated sodium channels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diana Conte Camerino Research Topics

Disease

5	Myotonia 01/2017 - 02/2012
4	Muscular Diseases (Myopathy) 01/2017 - 01/2004
3	Myotonia Congenita (Thomsen Disease) 09/2015 - 10/2013
2	Muscular Dystrophies (Muscular Dystrophy) 01/2017 - 02/2005
2	Muscular Atrophy (Muscle Atrophy) 01/2016 - 01/2015
2	Atrophy 01/2015 - 11/2007
2	Paralysis (Palsy) 01/2012 - 01/2006
1	Potassium aggravated myotonia 05/2016
1	Myotoxicity 01/2016
1	Hypertension (High Blood Pressure) 10/2014
1	Hypokalemia 01/2013
1	Hyperkalemia 01/2013
1	Neuralgia (Stump Neuralgia) 02/2012
1	Channelopathies 01/2006
1	Fibrosis (Cirrhosis) 02/2005
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2003
1	Muscle Weakness 10/2002
1	Inflammation (Inflammations) 10/2002

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2017 - 10/2002
4	Mexiletine (Mexitil)FDA LinkGeneric 01/2017 - 02/2012
3	Sodium Channel BlockersIBA 01/2017 - 02/2013
3	ChloridesIBA 09/2015 - 10/2002
3	CalciumIBA 10/2014 - 10/2002
2	AntioxidantsIBA 01/2017 - 01/2015
2	Polymethyl Methacrylate (Sol)IBA 01/2015 - 11/2007
2	Amino Acids FDA Link 01/2015 - 01/2004
2	Chloride Channels (Chloride Channel)IBA 05/2014 - 10/2013
2	Taurine FDA Link 01/2004 - 10/2002
2	SteroidsIBA 01/2003 - 10/2002
1	pyrrolineIBA 01/2017
1	Sodium Channels (Sodium Channel)IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	Atorvastatin (Lipitor)FDA Link 01/2016
1	CLC-1 channelIBA 09/2015
1	Anabolic Androgenic SteroidsIBA 01/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015
1	Nandrolone (Nortestosterone)IBA 01/2015
1	Stromal Interaction Molecule 1IBA 10/2014
1	Antihypertensive Agents (Antihypertensives)IBA 10/2014
1	AcidsIBA 05/2014
1	Tocainide (Tonocard)FDA Link 03/2014
1	Adrenergic Agents (Adrenergic Drugs)IBA 02/2013
1	iberiotoxinIBA 01/2013
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2013
1	ProdrugsIBA 02/2012
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2006
1	Insulin (Novolin)FDA Link 01/2006
1	Carbonic Anhydrase InhibitorsIBA 01/2006
1	Creatine Kinase (Creatine Phosphokinase)IBA 02/2005
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2005
1	Ion Channels (Ion Channel)IBA 01/2004
1	Insulin-Like PeptidesIBA 10/2002

Therapy/Procedure

1	Contraindications 01/2017
1	Therapeutics 05/2016
1	Bed Rest (Bedrest) 01/2012